Table 4.
Sociodemographic Variables for Patients Who Did and Did Not Complete at Least 42 Days of the Post-Placebo Phase (Analysis 3)
| Completers (n = 103) | Noncompleters (n = 14) | t/Z | P ≤ | Mean difference | 95% CI
|
||
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| Age (years) at admission (SD) | 31.6 (8.17) | 31.8 (4.95) | 0.10a | 0.92 | |||
| Duration (years) of illness (SD) | 11.8 (7.55) | 11.9 (5.11) | 0.06 | 0.95 | 0.1 | −3.99 | 4.26 |
| Years of education (SD) | 12.7 (2.13) | 14.0 (2.42) | 2.15 | 0.03 | 1.3 | 0.10 | 2.55 |
| Gender (F/M) | 34/69 | 2/12 | 0.22b | ||||
| Race (white/nonwhite) | 83/20 | 10/4 | 0.48b | ||||
| Married (yes/no) | 15/88 | 1/13 | 0.69b | ||||
| Tardive dyskinesia (yes/no) | 37/66 | 3/11 | 0.38b | ||||
| Smoker (yes/no) | 67/36 | 8/6 | 0.57b | ||||
| Verbal IQ (SD) | 90.5 (14.2) | 96.3 (16.3) | 1.32 | 0.19 | 5.9 | −2.92 | 14.7 |
| Performance IQ (SD) | 84.0 (10.2) | 88.6 (9.2) | 1.46 | 0.15 | 4.5 | −1.62 | 10.7 |
| Full scale IQ (SD) | 86.6 (11.8) | 92.1 (12.9) | 1.51 | 0.13 | 5.5 | −1.72 | 12.8 |
| CPZ equivalents | |||||||
| Baseline (SD) | 1385 (1354) | 1219 (726) | 0.29a | 0.78 | |||
| Days on placebo | 61.5 (45.7) | 46.7 (75.9) | 3.11a | 0.0019 | |||
| Days post-placebo to discharge | 431.2 (356) | 19.8 (10.9) | 6.05a | 0.0001 | |||
a
Mann–Whitney Z.
b
Fisher’s Exact.
CI, confidence interval.